The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

2.

Radioactive ion beams successfully treat animal tumors in study

3.

Early breast cancer detection may be possible with a wearable ultrasound scanner.

4.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.

5.

Many patients learn they could have cancer in the emergency department


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot